Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115286628B reveals efficient palladium catalyzed carbonylation for high purity indolo isoquinoline intermediates offering significant supply chain and cost advantages.
Patent CN115286553B reveals nickel-catalyzed carbonylation for indole synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel cobalt-catalyzed C-H activation method for tetrahydro-beta-carbolinones. High yields, scalable process for API intermediates replacing palladium.
Patent CN112321593B details a novel cobalt-catalyzed carbonylation route for indolo[1,2-a]quinazolin-6(5H)-ones, offering a cost-effective alternative to palladium methods for pharmaceutical intermediates.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation route for tetrahydro-beta-carbolinones, offering a cost-effective alternative to palladium methods for API intermediates.
Patent CN116444400B reveals a novel Pd-catalyzed synthesis for high-purity chiral amines. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN115260080B reveals efficient Pd-catalyzed carbonylation for indole-3-carboxamide. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN114014768A details a barium-free continuous flow synthesis for high-purity tranexamic acid, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Efficient synthesis of 1-benzylamino-substituted benzimidazoles via Cu/Pd catalysis. High yield, broad substrate scope, and scalable process for pharmaceutical manufacturing.
Patent CN115286578B reveals metal-free synthesis for high-purity pharmaceutical intermediates. Offers cost reduction and supply chain reliability for global buyers.
Novel cobalt catalyzed carbonylation method offers cost effective scalable production for pharmaceutical intermediates ensuring high purity and supply continuity
Patent CN115925692A details a robust Rh(III)-catalyzed route for trifluoromethyl enamines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd-catalyzed carbonylation method for indolo[2,1a]isoquinoline. High efficiency, scalable process for pharmaceutical intermediates supply chain optimization.
Patent CN115215810B reveals metal-free heating-promoted synthesis for high-purity triazole intermediates. Enables cost reduction in pharma manufacturing and reliable supply chain scalability.
Analysis of CN106380469A reveals a metal-free imidazolinone synthesis using molecular oxygen. This green method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Patent CN109651202B reveals a safe iridium-catalyzed route using dimethyl sulfoxide ylide and CO2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel cesium carbonate catalyzed method for high-purity chiral cyclopropyl amino acid. Reduces steps and solvent use for reliable pharmaceutical intermediate supply.
Patent CN112125856A details a novel Pd-catalyzed carbonylation using solid CO surrogates for safe, scalable production of high-purity quinazolinone derivatives.
Novel metal-free synthesis method for 5-trifluoromethyl triazoles offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.